{"entity":{"type":"insider","cik":"0001675490","url":"/insider/0001675490","json_url":"/insider/0001675490.json","name":"Vivo Panda Fund, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":18,"n_filings":3,"first":"2021-02-09","last":"2023-11-22","span_basis":"filed_date"},"name_variants":[{"name":"Vivo Panda Fund, L.P.","source":"filing","n_filings":3,"first_seen":"2021-02-09","last_seen":"2023-11-22"}],"transactions":[{"id":8024134,"accession":"0001213900-23-089692","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-23-089692","line_url":"/filing/0001213900-23-089692","is_derivative":false,"issuer_cik":"0001618788","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001618788","owner_cik":null,"owner_name":"Vivo Panda Fund, L.P.; Vivo Capital Fund VIII, L.P.; Vivo Capital Surplus Fund VIII, L.P.; Vivo Opportunity Fund Holdings, L.P.; Vivo Panda, LLC; Vivo Opportunity, LLC; Vivo Capital VIII, LLC","owner_display_name":"Vivo Panda Fund, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3400.0,"shares_display":"3,400","price_per_share":0.9,"price_display":"0.90","price_state":"stated","total_value":3060.0,"total_display":"3,060.00","total_whole":"3,060","shares_owned_after":1952302.0,"shares_owned_after_display":"1,952,302","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-21","filed_date":"2023-11-22","scope":"insider","n_lines":3},{"id":8727901,"accession":"0001213900-23-088909","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001213900-23-088909","line_url":"/filing/0001213900-23-088909","is_derivative":false,"issuer_cik":"0001618788","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001618788","owner_cik":null,"owner_name":"Vivo Capital Surplus Fund VIII, L.P.; Vivo Capital VIII, LLC; Vivo Capital Fund VIII, L.P.; Vivo Panda, LLC; Vivo Opportunity, LLC; Vivo Panda Fund, L.P.; Vivo Opportunity Fund Holdings, L.P.","owner_display_name":"Vivo Capital Surplus Fund VIII, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":54700.0,"shares_display":"54,700","price_per_share":0.92,"price_display":"0.92","price_state":"stated","total_value":50324.0,"total_display":"50,324.00","total_whole":"50,324","shares_owned_after":1954009.0,"shares_owned_after_display":"1,954,009","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-20","filed_date":"2023-11-20","scope":"insider","n_lines":3},{"id":8727892,"accession":"0001213900-23-088909","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001213900-23-088909","line_url":"/filing/0001213900-23-088909","is_derivative":false,"issuer_cik":"0001618788","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001618788","owner_cik":null,"owner_name":"Vivo Capital Surplus Fund VIII, L.P.; Vivo Capital VIII, LLC; Vivo Capital Fund VIII, L.P.; Vivo Panda, LLC; Vivo Opportunity, LLC; Vivo Panda Fund, L.P.; Vivo Opportunity Fund Holdings, L.P.","owner_display_name":"Vivo Capital Surplus Fund VIII, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Comon Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16354.0,"shares_display":"16,354","price_per_share":0.93,"price_display":"0.93","price_state":"stated","total_value":15209.22,"total_display":"15,209.22","total_whole":"15,209","shares_owned_after":1981474.0,"shares_owned_after_display":"1,981,474","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-17","filed_date":"2023-11-20","scope":"insider","n_lines":3},{"id":8727886,"accession":"0001213900-23-088909","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-23-088909","line_url":"/filing/0001213900-23-088909","is_derivative":false,"issuer_cik":"0001618788","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001618788","owner_cik":null,"owner_name":"Vivo Capital Surplus Fund VIII, L.P.; Vivo Capital VIII, LLC; Vivo Capital Fund VIII, L.P.; Vivo Panda, LLC; Vivo Opportunity, LLC; Vivo Panda Fund, L.P.; Vivo Opportunity Fund Holdings, L.P.","owner_display_name":"Vivo Capital Surplus Fund VIII, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":0.96,"price_display":"0.96","price_state":"stated","total_value":14400.0,"total_display":"14,400.00","total_whole":"14,400","shares_owned_after":1989685.0,"shares_owned_after_display":"1,989,685","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-16","filed_date":"2023-11-20","scope":"insider","n_lines":3},{"id":4924723,"accession":"0001209191-21-008758","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001209191-21-008758","line_url":"/filing/0001209191-21-008758","is_derivative":false,"issuer_cik":"0001618788","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001618788","owner_cik":null,"owner_name":"Vivo Panda, LLC; Vivo Opportunity Fund, L.P.; Vivo Panda Fund, L.P.; Vivo Capital Surplus Fund VIII, L.P.; Vivo Opportunity, LLC; Vivo Capital VIII, LLC; Vivo Capital Fund VIII, L.P.","owner_display_name":"Vivo Panda, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":226.0,"shares_display":"226","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":4520.0,"total_display":"4,520.00","total_whole":"4,520","shares_owned_after":1821483.0,"shares_owned_after_display":"1,821,483","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-09","filed_date":"2021-02-09","scope":"insider","n_lines":3},{"id":4924713,"accession":"0001209191-21-008758","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001209191-21-008758","line_url":"/filing/0001209191-21-008758","is_derivative":false,"issuer_cik":"0001618788","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001618788","owner_cik":null,"owner_name":"Vivo Panda, LLC; Vivo Opportunity Fund, L.P.; Vivo Panda Fund, L.P.; Vivo Capital Surplus Fund VIII, L.P.; Vivo Opportunity, LLC; Vivo Capital VIII, LLC; Vivo Capital Fund VIII, L.P.","owner_display_name":"Vivo Panda, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":350000.0,"shares_display":"350,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":7000000.0,"total_display":"7,000,000.00","total_whole":"7,000,000","shares_owned_after":1997216.0,"shares_owned_after_display":"1,997,216","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-09","filed_date":"2021-02-09","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001641281","name":"Bolt Biotherapeutics, Inc.","url":"/issuer/0001641281","role":"Ten percent owner","n_filings":3,"first_seen":"2021-02-09","last_seen":"2023-11-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001675490","retrieved_at":"2026-08-22T14:26:41+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}